SOAT1 and Dravet syndrome: JAK1-3 variants are identified in both ML-DS and TAM samples, however, gain-of-function mutations are only detected in ML-DS, highlighting that aberrant activation of JAK-STAT signaling is important for transition to leukemia (Labuhn et al., 2019).